CDK2 and ovarian cancer: Nevertheless, in ovary cancer, it is known that the increase in the percentage of cells in G1 in response to melatonin (range from 0 to 800 μM) is associated with a downregulation of cyclin-dependent kinases 2 and 4 (CDK2 and CDK4) [115].